Opinion of the Transparency Council – amendments to the drug programme B.90

At its meeting of 23 January 2023, the Transparency Council adopted Opinion No. 6/2023 on the legitimacy of amending the description of the B.90 drug programme “Treatment of motor disorders in the course of advanced Parkinson’s disease (ICD-10 G.20)”.

Publication with the minutes of the Transparency Council meeting